机译:当代成本效果分析与序贯芽孢杆菌和电动机丝塞霉素对比升降芽孢杆菌患者对高风险的非肌肉侵入性膀胱癌的患者进行比较
McGill Univ Ctr Hlth Div Urol Dept Surg Montreal PQ H3G 1A4 Canada;
McGill Univ Ctr Hlth Div Urol Dept Surg Montreal PQ H3G 1A4 Canada;
McGill Univ Ctr Hlth Div Urol Dept Surg Montreal PQ H3G 1A4 Canada;
McGill Univ Ctr Hlth Div Urol Dept Surg Montreal PQ H3G 1A4 Canada;
Univ Alberta Fac Med Dept Surg Div Urol Edmonton AB Canada;
Univ Toronto Dept Surg Univ Hlth Network Div Urol Toronto ON Canada;
Ottawa Hosp Res Inst Div Urol Ottawa ON Canada;
Univ British Columbia Dept Urol Sci Vancouver BC V5Z 1M9 Canada;
McGill Univ Ctr Hlth Div Urol Dept Surg Montreal PQ H3G 1A4 Canada;
cost-effectiveness; bacillus Calmette-Guerin (BCG); electromotive mitomycin; sequential therapy; non-muscle invasive bladder cancer;
机译:Re:当代成本效果分析比较序贯芽孢杆菌和电动机丝霉素对高风险非肌肉侵入性膀胱癌的患者的嗜肺芽孢杆菌患者
机译:回复:当代成本效益分析,比较高危非肌肉侵袭性膀胱癌患者序贯卡介苗和电动丝裂霉素与单独卡介苗的比较
机译:当代成本效果分析与序贯芽孢杆菌和电动机丝塞霉素对比升降芽孢杆菌患者对高风险的非肌肉侵入性膀胱癌的患者进行比较
机译:浅析浅析浅表膀胱癌膀胱内输液治疗
机译:基于卡介苗在膀胱癌中的作用方式进行靶向药物递送。
机译:AB152。膀胱内化疗联合卡介苗与卡介苗联合治疗中高风险非肌肉浸润性膀胱癌的系统评价和荟萃分析
机译:当代成本效益分析比较顺序芽孢杆菌和电动势丝霉素对高风险非肌肉侵袭性膀胱癌的患者单独的芽孢杆菌肺痘痘